BDX News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$52.20B

Volume

963.10K

Next Earnings

November 5th

Mkt Cap

$52.78B

Volume

963.10K

Next Earnings

November 5th

Chart Financials Earnings News About Dividends Insider Filings

BD's Revello Stent Shows Strong AGILITY Trial Results for PAD PatientsBecton, Dickinson and Company (BD) announced positive nine-month results from the AGILITY trial for its Revello Vascular Covered Stent in treating iliac artery disease. The trial met its primary endpoint with a 2.8% failure rate, 97.2% primary patency, and 98.3% freedom from clinically driven target lesion revascularization. The device remains investigational in the U.S. with clinical follow-up continuing through 36 months. The global iliac stent market is projected to grow at a 6.5% CAGR through 2033.Zacks Investment Research · Oct 15, 2026

Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsightThe global microbiology testing market is projected to grow from USD 6.3 billion in 2025 to USD 13.7 billion by 2034, driven by increasing infectious disease prevalence, antimicrobial resistance concerns, and stringent regulatory requirements. North America leads with 42% market share, while Asia-Pacific is expected to record the fastest growth. Key drivers include technological advancements in molecular diagnostics, laboratory automation, and expanding clinical diagnostic infrastructure.GlobeNewswire Inc. · Oct 14, 2026

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?Becton Dickinson (BDX) has demonstrated a strong earnings-beat streak, with an average surprise of 3.78% over the last two quarters. The company currently has a positive Earnings ESP of +0.21% combined with a Zacks Rank #3 (Hold), suggesting another potential earnings beat in its November 5, 2026 report. Stocks with this combination historically beat consensus estimates nearly 70% of the time.Zacks Investment Research · Oct 9, 2026

BDX Expands U.S. Manufacturing With $19B Healthcare InvestmentBecton, Dickinson and Company (BD) announced a landmark partnership with the U.S. Government to invest $19 billion in domestic manufacturing expansion, including $3 billion toward manufacturing capacity. The company aims to increase domestically supplied essential medical consumables to 80% and manufacture all U.S.-used needles domestically with American-made steel. The agreement provides tariff protection on covered products, though financial impact remains unquantified pending finalization of tariff rates and implementation timing.Zacks Investment Research · Oct 7, 2026

Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexThe Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, and technology adoption, with the global market expected to reach $318.77 billion by 2031. However, tariffs, commodity inflation, and policy-driven pricing changes present headwinds. Five key stocks—McKesson, Cardinal Health, Becton Dickinson, Merit Medical Systems, and ProDex—are highlighted as well-positioned to capitalize on favorable industry trends through 2026.Zacks Investment Research · Oct 2, 2026

Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsightThe global liver cancer diagnostics market is projected to grow from USD 10.5 billion in 2025 to USD 19.8 billion by 2034, driven by rising hepatocellular carcinoma incidence, increasing chronic liver disease prevalence, and advances in diagnostic technologies including liquid biopsy, AI-assisted imaging, and blood-based biomarkers. North America leads the market with 41% share, while Asia-Pacific is expected to be the fastest-growing region.GlobeNewswire Inc. · Oct 1, 2026

5 Medical Dental Supply Stocks to Watch as Industry Prospects ImproveThe Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, AI automation, and aging demographics. The global medical supplies market is expected to reach $318.77 billion by 2031 with a 10% CAGR. However, tariffs, commodity inflation, and pharmaceutical pricing changes remain headwinds. Key industry players show mixed near-term prospects with the industry trading at favorable valuations compared to broader markets.Zacks Investment Research · Oct 1, 2026

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market ShareThe global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.GlobeNewswire Inc. · Sep 4, 2026

Syringe Filling Machine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031), Syringe Filling Machine Market to Reach USD 2.99 BillionThe global syringe filling machine market is projected to grow from USD 2.09 billion in 2026 to USD 2.99 billion by 2031 at a 7.41% CAGR. Growth is driven by rising demand for prefilled syringes, automated fill-finish lines for biologics, and regulatory focus on aseptic accuracy. Automated systems dominate with 63.92% market share, while servo-driven piston technology leads at 44.05%. Asia-Pacific emerges as the fastest-growing region at 10.72% CAGR, driven by biologics capacity expansion.GlobeNewswire Inc. · Sep 1, 2026

Antimicrobial Resistance Surveillance Market (2026-2031) - Rising Prevalence of Drug-Resistant Infections to Drive GrowthThe global antimicrobial resistance surveillance market is projected to grow from USD 6.24 billion in 2025 to USD 8.66 billion by 2031, expanding at a 5.62% CAGR. Growth is driven by rising drug-resistant infections, government funding initiatives, and adoption of AI, molecular diagnostics, and genomic sequencing technologies. North America leads with 42.15% market share, while Asia-Pacific is the fastest-growing region at 6.41% CAGR. High implementation costs remain a challenge, particularly in resource-constrained settings.GlobeNewswire Inc. · Aug 25, 2026

BDXBecton, Dickinson and Co.

BDX

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any BDX yet.

Related Tickers

Earnings

Dividends

Last · Sep 9Quarterly

Amount$1.05

Yield2.07%

Annual$3.98

Mkt Cap

$52.20B

Volume

963.10K

Next Earnings

November 5th